Chemical biology for the development of new therapies (Q19945): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): ChemBioDrug has been the subject of excellence in problem-oriented research, the purpose of which is the development of new potential therapeutics, viral diseases and metabolic disorders on the principle of ‘undruggable’ interactions of biomolecules that are not achieved by classical medicinal chemistry. It is a condition to concentrate the Centre’s excellence capacities (Center) in a multidisciplinary design team, its further development, the a...)
(‎Removed claims)
Property / EU contribution
354,628,892.49 Czech koruna
Amount354,628,892.49 Czech koruna
UnitCzech koruna
 
Property / EU contribution: 354,628,892.49 Czech koruna / rank
Normal rank
 
Property / EU contribution
14,185,155.6996 Euro
Amount14,185,155.6996 Euro
UnitEuro
 
Property / EU contribution: 14,185,155.6996 Euro / rank
Preferred rank
 
Property / EU contribution: 14,185,155.6996 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / EU contribution: 14,185,155.6996 Euro / qualifier
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 17:00, 3 March 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Chemical biology for the development of new therapies
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    497,027,179.4 Czech koruna
    0 references
    19,881,087.176 Euro
    10 January 2020
    0 references
    71.3499999976058 percent
    0 references
    1 January 2018
    0 references
    31 December 2022
    0 references
    Ústav organické chemie a biochemie AV ČR, v. v. i.
    0 references

    50°5'39.41"N, 14°20'3.98"E
    0 references

    50°6'17.86"N, 14°22'51.35"E
    0 references
    16000
    0 references
    Předmětem projektu ChemBioDrug je špičkový problémově orientovaný výzkum, jehož účelem je vývoj nových potenciálních terapeutik rakoviny, virových onemocnění a metabolických poruch na principu specifické inhibice tzv. undruggable interakcí biomakromolekul, na které klasická medicinální chemie nedosáhne. Podmínkou je soustředění excelentních kapacit ÚOCHB (Centra) v multidisciplinárním projektovém týmu, jeho další rozvoj, doplnění klíčového vybavení a posílení mezinárodní výzkumné spolupráce. a. (Czech)
    0 references
    ChemBioDrug has been the subject of excellence in problem-oriented research, the purpose of which is the development of new potential therapeutics, viral diseases and metabolic disorders on the principle of ‘undruggable’ interactions of biomolecules that are not achieved by classical medicinal chemistry. It is a condition to concentrate the Centre’s excellence capacities (Center) in a multidisciplinary design team, its further development, the addition of key equipment and the strengthening of international research cooperation. (English)
    0 references

    Identifiers

    CZ.02.1.01/0.0/0.0/16_019/0000729
    0 references